Ebos Group receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EBOS Group Ltd (EBO)
EBOS Group Ltd stock price live, this page displays NZ EBO stock exchange data. View the EBO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the EBOS Group Ltd real time stock price chart below.
What Is the EBOS Group Ltd Stock Price Today?
The EBOS Group Ltd stock price today is 23.28.
What Is the Stock Symbol for EBOS Group Ltd?
The stock symbol for EBOS Group Ltd is "EBO."
What Stock Exchange Does EBOS Group Ltd Trade On?
EBOS Group Ltd is listed and trades on the New Zealand stock exchange.
Is EBOS Group Ltd a Good Stock to Buy?
Determining whether EBOS Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EBO quote. (ISIN: NZEBOE0001S6)
What Is the EBOS Group Ltd Stock Price Today?
The EBOS Group Ltd stock price today is 23.28.
What Is the Stock Symbol for EBOS Group Ltd?
The stock symbol for EBOS Group Ltd is "EBO."
What Stock Exchange Does EBOS Group Ltd Trade On?
EBOS Group Ltd is listed and trades on the New Zealand stock exchange.
Is EBOS Group Ltd a Good Stock to Buy?
Determining whether EBOS Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EBO quote. (ISIN: NZEBOE0001S6)
23.28
+0.03(+0.13%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.11
23.70
52 wk Range
19.00
41.49
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.1123.70
52 wk Range
19.0041.49
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
EBO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
28.02
Upside
+20.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Pays a significant dividend to shareholders
Ebos Group receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Ebos Group receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Ebos Group receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
1 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 28.02
(+20.35% Upside)
EBOS Group Ltd Earnings Call Summary for H2/2026
- EBOS FY26 revenue rose 9.9% to AUD 13.5B, underlying EBITDA up 5.0% to AUD 614M, both within guidance; shares jumped 5.5% to $23.
- Completed AUD 360M distribution center renewal program; new Kemps Creek facility operating 20% more productively than predecessor.
- FY27 EBITDA guidance of AUD 635M-655M implies ~5% growth; capex to drop to AUD 100M from AUD 145M, boosting free cash flow.
- Animal Care fastest-growing division with 34.6% revenue growth; 70% of group EBITDA now from higher-growth, higher-return businesses.
- Company has AUD 150M capacity for bolt-on M&A faces margin pressure from pharmacy competition and Chemist Warehouse NZ contract ending 2026.
Last Updated: 2026-08-18, 08:16 p/m
Read Full TranscriptEarnings
Latest Release
Feb 25, 2026
EPS / Forecast
0.61 / --
Revenue / Forecast
6.77B / --
Compare EBO to Peers and Sector
Metrics to compare | EBO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEBOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.9x | 19.5x | −0.3x | |
PEG Ratio | - | 0.03 | 0.00 | |
Price/Book | 1.5x | 1.8x | 2.6x | |
Price / LTM Sales | 0.3x | 1.1x | 3.1x | |
Upside (Analyst Target) | 20.4% | 13.8% | 48.5% | |
Fair Value Upside | Unlock | 16.6% | 6.3% | Unlock |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services. It also offers community-based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five-step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; dog and cat food, and treats; and surgical devices and medical consumables. Further, it provides pet nutrition, treats, clean-up, and grooming products and accessories; supplies pet medicines and other products to veterinary clinics and specialty retailers; manufactures and supplies dog rolls; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the EBOS (EBO) Stock Price Today?
The EBOS stock price today is 23.28 NZD.
What Stock Exchange Does EBOS Trade On?
EBOS is listed and trades on the New Zealand Exchange.
What Is the Stock Symbol for EBOS?
The stock symbol for EBOS is "EBO."
Does EBOS Pay Dividends? What’s The Current Dividend Yield?
The EBOS dividend yield is 5.32%.
What Is the EBOS Market Cap?
As of today, EBOS market cap is 4.88B NZD.
What Is EBOS's Earnings Per Share (TTM)?
The EBOS EPS (TTM) is 1.09.
From a Technical Analysis Perspective, Is EBO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has EBOS Stock Split?
EBOS has split 5 times.
How Many Employees Does EBOS Have?
EBOS has 5800 employees.
What is the current trading status of EBOS (EBO)?
As of Aug 21, 2026, EBOS (EBO) is trading at a price of 23.28 NZD, with a previous close of 23.25 NZD. The stock has fluctuated within a day range of 23.11 NZD to 23.70 NZD, while its 52-week range spans from 19.00 NZD to 41.49 NZD.
What Is EBOS (EBO) Price Target According to Analysts?
The average 12-month price target for EBOS is 28.02 NZD, with a high estimate of 34.72346484 NZD and a low estimate of 21.7843424 NZD. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +20.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.